| Experts Supporting the Science of ProArgi-9 |
|
|
|
|
Certainly, the Nobel Prize in Medicine for the discovery of Nitric Oxide as a signaling molecule in the cardiovascular system was an enormous accomplishment in validating the importance this miracle molecule, Nitric Oxide, plays in cardiovascular health as well as many other systems in the human body. Since this remarkable discovery, several of the worlds leading cardiovascular scholars have made profound contributions in this arena and continue to propel this scientific emphasis forward.
Victor Dzau, MDChancellor for health affairs, Duke Medicine, and president and CEO of Duke University Health System, Victor Dzau understands “that meaningful reform of the U.S. health-care system is front and center on the minds of legislators, business leaders, health-care professionals, and the millions of people across the country who voted for the kind of reform outlined by the Obama campaign. The need for this reform in the near term is undeniable.” “I believe the next few decades are also critically important to making progress on the global-health front. Leading academic medical centers like Duke's have a unique opportunity to exercise leadership in extending the scope of global-health initiatives. These will include not only improving the treatment of disease, but also training health-care providers and conducting research that can be effectively translated and applied for the benefit of people around the world.” Before coming to Duke, Dzau was the Hersey Professor of the Theory and Practice of Physic (Medicine) at Harvard Medical School, chairman of the Department of Medicine at Brigham and Women's Hospital, and physician in chief and director of research at Brigham and Women's Hospital, Boston. Prior to his work at Harvard and Brigham and Women's, he served as Arthur Bloomfield Professor and chairman of the Department of Medicine at Stanford University.
|







